Answers are grounded in this paper and cite their sources.
Review demonstrates microfluidic CRISPR-Cas platforms enable sensitive marine contaminant detection, highlighting translation hurdles like real-seawater validation and biofouling.
Marine ecosystems face escalating threats from heavy metals, harmful algal bloom tox-ins, pathogens, and antibiotic resistance genes, yet conventional detection methods re-main laboratory-dependent and incapable of real-time, multiplexed field monitoring. CRISPR-Cas diagnostics, leveraging programmable Cas12a/Cas13a trans-cleavage for attomolar-level sensitivity, offers a transformative solution when integrated with mi-crofluidic platforms that provide the automation and miniaturisation required for field deployment. This review systematically examines this emerging convergence across four marine target classes: heavy metals, biotoxins, pathogens, and resistance genes alongside integration architectures, signal readout strategies, and comparative performance benchmarking. We identify that only a small fraction of reported platforms have been validated in authentic seawater, with cross-class multiplexing, biofouling resistance during autonomous deployment, and regulatory standardisation remaining largely unaddressed. By synthesising this rapidly developing literature and articulating these unresolved challenges, this review provides a foundational reference and research agenda for translating microfluidic-CRISPR biosensors from laboratory proof-of-concept to operational marine environmental surveillance.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: